News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
160 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21515)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
3 (211)
4 (156)
5 (138)
6 (132)
7 (99)
10 (143)
11 (166)
12 (109)
13 (118)
14 (57)
17 (86)
18 (155)
19 (140)
20 (160)
21 (114)
24 (193)
25 (221)
26 (183)
27 (202)
28 (167)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Up to 4,100 Children Victims of Sanofi’s Epilepsy Drug, Says French Regulator
April 20, 2017
·
2 min read
Drug Development
Enanta Pharmaceuticals, Inc. Announces 99 Percent SVR12 Rate In Chronic HCV Patients With Compensated Cirrhosis Treated With AbbVie’s Investigational, Pan-Genotypic, Ribavirin-Free Regimen Of Glecaprevir/Pibrentasvir (G/P)
April 20, 2017
·
7 min read
Business
Bicycle Therapeutics Announces A Candidate Preclinical Milestone In Its Ophthalmology Alliance With ThromboGenics NV
April 20, 2017
·
4 min read
Business
PharMerica Announces First Quarter 2017 Earnings Call And Webcast
April 20, 2017
·
1 min read
Biotech Bay
RenovoRx Release: Researchers Report Survival Benefits With Use Of RenovoCath In Patients With Locally Advanced Pancreatic Tumors
April 20, 2017
·
2 min read
Business
Foundation Medicine, Inc. Announces Timing For First Quarter 2017 Financial Results And Conference Call
April 20, 2017
·
1 min read
FDA
FDA Clears Halyard Health’s COOLIEF* for the Management of Osteoarthritis Knee Pain
April 20, 2017
·
6 min read
Deals
DePuy Synthes Acquires Tissue Regeneration Systems’ 3D Printing Technologies To Treat Bone Defects
April 20, 2017
·
4 min read
Business
Mazor Robotics To Report First Quarter Financial Results On May 10, 2017
April 20, 2017
·
1 min read
Drug Development
AbbVie’s Investigational, Pan-Genotypic, Ribavirin-Free Regimen Of Glecaprevir/Pibrentasvir (G/P) Achieved 99 Percent SVR(12) Rate In Chronic Hepatitis C Patients With Compensated Cirrhosis
April 20, 2017
·
7 min read
Previous
3 of 16
Next
